PD-L1 protein expression is assessed in GC using CPS, which is the number of PD-L1 positively-stained cells (i.e., tumor cells, lymphocytes, and macrophages) divided by the total number of viable tumor cells, multiplied by 100%. The gene discussed is CD274; the disease is neoplasm.